126 related articles for article (PubMed ID: 35763382)
21. High expression of long noncoding RNA Sox2ot is associated with the aggressive progression and poor outcome of gastric cancer.
Zou JH; Li CY; Bao J; Zheng GQ
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4482-4486. PubMed ID: 27874951
[TBL] [Abstract][Full Text] [Related]
22. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
Deng J; Liang Y; Liu C; He S; Wang S
Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer.
Xu YH; Tu JR; Zhao TT; Xie SG; Tang SB
Int J Oncol; 2019 Jan; 54(1):295-305. PubMed ID: 30431074
[TBL] [Abstract][Full Text] [Related]
24. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA Loc344887 is a potential prognostic biomarker in non-small cell lung cancer.
Wu B; Zhang XJ; Li XG; Jiang LS; He F
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3808-3812. PubMed ID: 28975987
[TBL] [Abstract][Full Text] [Related]
26. A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.
Pan F; Yao J; Chen Y; Zhou C; Geng P; Mao H; Fang X
Int J Clin Exp Pathol; 2014; 7(6):2838-49. PubMed ID: 25031703
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
Tan J; Yang L
Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of long noncoding RNA RP11-713B9.1 contributes to the cell viability in non‑small cell lung cancer (NSCLC).
Cai J; Wang X; Huang H; Wang M; Zhang Z; Hu Y; Yu S; Yang Y; Yang J
Mol Med Rep; 2017 Sep; 16(3):3694-3700. PubMed ID: 28765887
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA JPX correlates with poor prognosis and tumor progression in non-small-cell lung cancer by interacting with miR-145-5p and CCND2.
Jin M; Ren J; Luo M; You Z; Fang Y; Han Y; Li G; Liu H
Carcinogenesis; 2020 Jul; 41(5):634-645. PubMed ID: 31253987
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
[TBL] [Abstract][Full Text] [Related]
32. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
Zhang L; Zhou XF; Pan GF; Zhao JP
Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer.
Luo J; Tang L; Zhang J; Ni J; Zhang HP; Zhang L; Xu JF; Zheng D
Tumour Biol; 2014 Nov; 35(11):11541-9. PubMed ID: 25129441
[TBL] [Abstract][Full Text] [Related]
35. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
36. Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression and poor prognosis in patients with non-small cell lung cancer.
Zhao QS; Li L; Zhang L; Meng XW; Li LL; Ge XF; Li ZP
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3031-4. PubMed ID: 27460731
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding nature brain-derived neurotrophic factor antisense is associated with poor prognosis and functional regulation in non-small cell lung caner.
Shen M; Xu Z; Jiang K; Xu W; Chen Y; Xu Z
Tumour Biol; 2017 May; 39(5):1010428317695948. PubMed ID: 28459374
[TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA CTD-2245E15.3 Promotes Anabolic Enzymes ACC1 and PC to Support Non-Small Cell Lung Cancer Growth.
Wang C; Meng X; Zhou Y; Yu J; Li Q; Liao Z; Gu Y; Han J; Linghu S; Jiao Z; Wang T; Zhang CY; Chen X
Cancer Res; 2021 Jul; 81(13):3509-3524. PubMed ID: 33941610
[TBL] [Abstract][Full Text] [Related]
39. Linc8087 predicts favorable prognosis and inhibits cell migration and invasion in NSCLC.
Qi Q; Chen C; Liu C; Zhang B; Ma Y; Zhang H; Huang W; Wang C
Pathol Res Pract; 2021 Sep; 225():153569. PubMed ID: 34391179
[TBL] [Abstract][Full Text] [Related]
40. Investigation of LINC00342 as a poor prognostic biomarker for human patients with non-small cell lung cancer.
Tang H; Zhao L; Li M; Li T; Hao Y
J Cell Biochem; 2019 Apr; 120(4):5055-5061. PubMed ID: 30320899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]